(1 - 40 von 57
)
Experimental Drug T-DM1 Clinical Trials Encouraging Against...
abcnews.go.com
T-DM1, an experimental drug, showed promise in clinical trials against HER2-positive breast cancer. Patients who took the drug were free of disease longer than...
Fighting the Breast Cancer Epidemic: Interview with Dr. Sara Hurvitz...
article.wn.com
Sara Hurvitz, MD is an Assistant Clinical Professor of Medicine in the Division of Hematology-Oncology at UCLA specializing in the treatment of breast cancer,...
Breast cancer treatment has evolved. Here’s where we are.
healthcare-in-europe.com
There is no “one size fits all approach” when it comes to treating breast cancer. The disease is made up of several subtypes, and ideally each type should be...
UCLA Jonsson Comprehensive Cancer Center : Sara Hurvitz
cancer.ucla.edu
Cancer center at the University of California, Los Angeles. Dr. Sara Hurvitz leads studies aimed at improving breast cancer care.
sortiert nach Relevanz / Datum